More on atorvastatin and fibrinogen (Q74176515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

More on atorvastatin and fibrinogen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

C Otto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Schwandt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

591-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Effect of atorvastatin on plasma fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

7 January 2021

Statins and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900472-X

10.1016/S0021-9150(00)00472-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944081%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference